Top Entrepreneurs’ Advice →
Managing director, the Foundry Group
Partner, Third Rock Ventures
Nobel Laureate, Professor of Biology, Caltech
Founder, Gilt Groupe
CEO of Dynamis Corporation
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
CEO and co-founder of BoostSuite
October 20, 2016 ·
October 27, 2016 ·
Cambridge, MA-based Idenix Pharmaceuticals, a maker of hep C drugs, was acquired by Merck in June 2014.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2016, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.